A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV

Investigative Ophthalmology and Visual Science

Volumn 42, Issue 1, 2001, Pages 38-46

  Lange, N ^a   Ballini, J P ^a   Wagnieres, G ^a   Van den Bergh, H ^a  

^a EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOSENSITIZING AGENT;

ANIMAL CELL; ARTICLE; CHORIOALLANTOIS; DRUG SCREENING; FLUORESCENCE ANGIOGRAPHY; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME;

ALLANTOIS; ANIMALS; CAPILLARY PERMEABILITY; CHICK EMBRYO; CHORION; CHOROIDAL NEOVASCULARIZATION; DRUG EVALUATION, PRECLINICAL; FLUORESCEIN ANGIOGRAPHY; FLUORESCENT DYES; INJECTIONS, INTRAVENOUS; MICROSCOPY, FLUORESCENCE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RHODAMINES;

EID: 0035170073     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Age related macular degeneration: A review of experimental treatments
2. Argon laser photocoagulation for neovascular maculopathy: Five years results from randomized clinical trials
3. Laser photocoagulation for juxtafoveal choroidal neovascularization: Five years results from randomized clinical trials
4. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration: Updated findings from two clinical trials
5. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degenaration: Results of a randomized clinical trial
6. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration: Results of a randomized clinical trial
7. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: The influence of initial size and initial visual acuity
8. Vascular effects of photodynamic therapy
9. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration
10. Photodynamic therapy with verteportin for choroidal neovascularization caused by age-related macular degeneration
11. Photodynamic therapy of subfoveal choroidal neovascularization: Clinical and angtographic examples
12. Preliminary clinical results of Lu-Tex fluorescence pharmacokinetic and photodynamic therapy to treat choroidal neovascularization
13. SnET2 study begins ophthalmic clinical trials for CNV
14. Photodynamic laser cyclo-destruction with chloroaluminium sulfonated phthalocyanine (CASPci or photofrin (PII) vs Nd:YAG laser cyclodestruction in a pigmented rabbit model
15. Photothrombosis of retinal and choroidal vessels in rabbit eyes using chloroaluminium sulfonated phthalocyanine and a diode laser
16. Phthalocyanine photodynamic therapy: New strategy for closure of choroidal neovascularization
17. Phthalocyanine photodynamic therapy of experimental iris neovascularization
18. Photodynamic therapy of subretinal neovascularization in the monkey eye
19. Selective occlusion of choroidal neovascularization of photodynamic therapy with a water soluble photosensitizer, ATX-S10
20. Fluorescence properties of a hydrophilic sensitizer in pigmented rats, rabbits, and monkeys
21. Potential of photodynamic therapy with a second-generation sensitizer: Mono-L-aspartyl chlorin e6
22. In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization
23. Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative
24. Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative
25. Effects of photodynamic therapy using verteportin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment
26. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization
27. Injuries induced by diffuse photodynamic action in retina and choroid of albino rats
28. Photodynamic retinal vascular thrombosis
29. Vascular damage during PDT as monitored in the chick chorioallantoic membrane
30. Rôle of neovasculature and vascular permeability on the tumor retention of photodynamic agents
31. Photodynamic efficacy of naturally occurring porphyrins in endothelial cells in vitro and microvasculature in vivo
32. Photodynamic damage by liposome-bound porphycenes: Comparison between in vitro and in vivo models
33. Systematic application of photosensitizers in the chick chorioallantoic membrane model: Photodynamic response of CAM vessels and 5-aminolevulinic acid uptake kinetics by transplantable tumors
34. New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: The gelatine sponge/CAM assay
35. Tumor angiogenesis factor
36. A computer-based method to quantify the classic pattern of choroidal neovascularization in order to monitor photodynamic therapy
37. Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes
38. The effect of aging on the physical stability of liposome dispersions
39. Oxidative stability of liposomes prepared from soybean PC, chicken egg PC, and salmon egg PC
40. Degradation of phosphatidylcholine in liposomes containing carboplatin in dependence on composition and storage conditions
41. In situ labelling of vascular endothelium with fluorescent acetylated low density lipoprotein
42. Quantitation of angiogenesis antiangiogenesis in the chick embryo chorioallantoic membrane